Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors

被引:172
作者
Hatakeyama, Shuji
Sugaya, Norio
Ito, Mutsumi
Yamazaki, Masahiko
Ichikawa, Masataka
Kimura, Kazuhiro
Kiso, Maki
Shimizu, Hideaki
Kawakami, Chiharu
Koike, Kazuhiko
Mitamura, Keiko
Kawaoka, Yoshihiro
机构
[1] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol,Minato Ku, Tokyo 1088639, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Infect Dis, Tokyo, Japan
[3] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo, Japan
[4] Keiyu Hosp, Dept Pediat, Kanagawa, Japan
[5] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan
[6] Zama Childrens Clin, Kanagawa, Japan
[7] Isehara Kyodo Hosp, Dept Pediat, Isehara, Kanagawa, Japan
[8] Kawasaki City Inst Publ Hlth, Kanagawa, Japan
[9] Yokohama City Inst Hlth, Kanagawa, Japan
[10] Eiju Gen Hosp, Dept Pediat, Tokyo, Japan
[11] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2007年 / 297卷 / 13期
关键词
D O I
10.1001/jama.297.13.1435
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Very little is known about the frequency of generation and transmissibility of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. Furthermore, transmission of resistant virus, whether influenza A or B, has not been recognized to date. Objective To assess the prevalence and transmissibility of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. Design, Setting, and Patients Investigation of the neuraminidase inhibitor sensitivity of influenza B isolates from 74 children before and after oseltamivir therapy and from 348 untreated patients with influenza ( including 66 adults) seen at 4 community hospitals in Japan during the 2004-2005 influenza season. Four hundred twenty-two viruses from untreated patients and 74 samples from patients after oseltamivir therapy were analyzed. Main Outcome Measure Sialidase inhibition assay was used to test the drug sensitivities of influenza B viruses. The neuraminidase and hemagglutinin genes of viruses showing reduced sensitivity to neuraminidase inhibitors were sequenced to identify mutations that have the potential to confer reduced sensitivity to these drugs. Results In 1 (1.4%) of the 74 children who had received oseltamivir, we identified a variant with reduced drug sensitivity possessing a Gly402Ser neuraminidase substitution. We also identified variants with reduced sensitivity carrying an Asp198Asn, Ile222Thr, or Ser250Gly mutation in 7 (1.7%) of the 422 viruses from untreated patients. Review of the clinical and viral genetic information available on these 7 patients indicated that 4 were likely infected in a community setting, while the remaining 3 were probably infected through contact with siblings shedding the mutant viruses. Conclusions In this population, influenza B viruses with reduced sensitivity to neuraminidase inhibitors do not arise as frequently as resistant influenza A viruses. However, they appear to be transmitted within communities and families, requiring continued close monitoring.
引用
收藏
页码:1435 / 1442
页数:8
相关论文
共 30 条
[1]   THE 2.2-A RESOLUTION CRYSTAL-STRUCTURE OF INFLUENZA-B NEURAMINIDASE AND ITS COMPLEX WITH SIALIC-ACID [J].
BURMEISTER, WP ;
RUIGROK, RWH ;
CUSACK, S .
EMBO JOURNAL, 1992, 11 (01) :49-56
[2]   Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo [J].
Carr, J ;
Ives, J ;
Kelly, L ;
Lambkin, R ;
Oxford, J ;
Mendel, D ;
Tai, L ;
Roberts, N .
ANTIVIRAL RESEARCH, 2002, 54 (02) :79-88
[3]   Pharmacoscintigraphic evaluation of lung deposition of inhaled zanamivir in healthy volunteers [J].
Cass, LMR ;
Brown, J ;
Pickford, M ;
Fayinka, S ;
Newman, SP ;
Johansson, CJ ;
Bye, A .
CLINICAL PHARMACOKINETICS, 1999, 36 (Suppl 1) :21-31
[4]   SEQUENCE AND STRUCTURE ALIGNMENT OF PARAMYXOVIRUS HEMAGGLUTININ-NEURAMINIDASE WITH INFLUENZA-VIRUS NEURAMINIDASE [J].
COLMAN, PM ;
HOYNE, PA ;
LAWRENCE, MC .
JOURNAL OF VIROLOGY, 1993, 67 (06) :2972-2980
[5]   Antiviral drugs in current clinical use [J].
De Clercq, E .
JOURNAL OF CLINICAL VIROLOGY, 2004, 30 (02) :115-133
[6]   Brief report - Oseltamivir resistance during treatment of influenza A (H5N1) infection [J].
de Jong, MD ;
Thanh, TT ;
Khanh, TH ;
Hien, VM ;
Smith, GJD ;
Chau, NV ;
Cam, BV ;
Qui, PT ;
Ha, DQ ;
Guan, Y ;
Peiris, JSM ;
Hien, TT ;
Farrar, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (25) :2667-2672
[7]  
Dolin R., 2005, PRINCIPLES PRACTICE, Vp, P2060
[8]   Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors [J].
Gubareva, LV .
VIRUS RESEARCH, 2004, 103 (1-2) :199-203
[9]   Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus [J].
Gubareva, LV ;
Matrosovich, MN ;
Brenner, MK ;
Bethell, RC ;
Webster, RG .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (05) :1257-1262
[10]   Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir [J].
Gubareva, LV ;
Kaiser, L ;
Matrosovich, MN ;
Soo-Hoo, Y ;
Hayden, FG .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (04) :523-531